Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why would the CEO of POTN be associated with RSHN
It is not a scam.
Much bigger things coming imo
Mav
Low volume pullback
Tree shake 101
Dont loose your position cause u got caught up in the emotions of a dip... lol
How many millions traded over the past few days at these levels?
All those that bought in this range are holding for much higher
Mav
RSHN low volume pull back
Consolidation 101
All the flipp3rs sold trying to reload using scare tactics so their bids get filled...
DSGT - patiently waiting....
Market cap correction is WAY overdue here. We have reached rock bottom and theres nowhere to go but up.
Mav
RBIZ - extremely UNDERVALUED here
RSHN - smart money loaded today IMHO
Pounding the table and the ask all day!!
Locked for copper and silver!
RSHN - LOADED LOCKED and BUCKLED UP!!
Its going to be a fun ride. AND!/APR* 2.0 multi pennie runner in the making.
Dont miss the train!!
Mav
NPHC- time will tell
Up 100% on the year.
Recent highs this year were 1000% up from last year at this time.
heres a question nobody will answer:
SHOW US ANOTHER BIOTECH WITH SIMILAR PRODUCTS AND INTELLECTUAL PROPERTY THATS TRADING AT 3 MIL MARKET CAP......
I'll be waiting
Mav
Great post. MUST read email confirmation.
Thanks for the DD
Keep up the good work. I agree RSHN is a total buy opportunity here
Mav
RBIZ loading and HOLDING.
Simple as that.
Mav
RSHN - forming the launch pad to pennies
Churning out impatient, closed minded bid wacking amatuer trip holders.
Gaining a new base of shareholders looking for much higher prices then a few ticks.
THE SAME EXACT TRADING PATTERN OCCURED ON AND!.... IT RAN TO .03+++.
Its coming.
Mark it
Mav
RSHN - buckle up for launch to copper
All systems go Houston we are ready for lift off!!
RSHN
Mav
RSHN - im looking for this as well...
a PR detailing the mayweather deal Will send this to silver and beyond fast n FURIOUS !!
Mark it.
Mav
RSHN - i believe its real...
the XYZHEMP.com clearly illustrates the connection and insinuates it is in negotiations. IMHO If it wasnt real it would not still be up.
This kind of celebrity endorsement will garner enormous amount of attention, mayweather would know almost instantly and his legal team would have it down already.
I thik this was a hint to all his buddies and friends to get on the train. Thus the reason we see unprecedented dollar volume.
Those who sold are typical trip traders dumping bid wacking purposely trying to get it to go back down so they can reload. That is the game down there. That was the action on friday. Held up extremely well imo.
Now sub penny and up above the game is holding from low to high and riding out each wave up. First wave achieved. 2nd and 3rd wave coming soon imo. They are almost always progressively bigger
The next few trading sessions will say alot about the stock. If the company is smart they are ready will more news to keep the momentum in their stock price
Alot of money got in at these levels for gains far beyond a few ticks. We will see how it unfolds in the weeks ahead!
GLTUA
RSHN
Mav
RSHN.
Watch how many bears turn into bulls when their bids get filled.
OTC 101
Mav
Mayweather even whispers RSHN...
And this stock will run for weeks n weeks.
I would not put it past being possible... alot of money to be made. Exponential gains. All from a simple endorsement
Maybe mayweather and friends have loaded up on RSHN as they get a deal inked.
Its a exciting story for sure!!! most stocksive seen that run the furthest and hardest have exciting stories and zero revenues!! Its crazy but its true.
Never underestimate the power of celebrity endorsement!
Mav
RBIZ - 6 figure return potential imo
U dont make 6 figure returns by buying today and selling tomorrow for 450 profit
It is not as simple as buying and holding either. It is knowing which stocks are vasyly UNDERVALUED and REAL. Which deserve to be accumulated held and when they have reached their max potential.
My friends and i specialize in finding these gems and loading up on them. All of my good friends are here for a reason!!
Multi pennies are coming when u least expect it imo!
Mav
SSOF is vastly UNDERVALUED here
A big run and market cap correction is coming.
Imho .05 to .10 is very possible
Mav
RBIZ - focus on THE DD and FUNDEMENTALS
IGNORE EVERYTHING AND EVERYONE ELSE.
Mav
RBIZ - 15M + dollar in 20 sessions.
Dont fall for the BS and sell yourself short. Flipp3rs can flip and brag about 450$ profit.... LOL that is hilarious...
Real players load and hold the right stocks. Last year i alerted the same traders on a play @ .004 and they laughed at me. It went from .004 to .10+ i made 6 figures on that.
The key is to know what you own and do your DD. Pay way less attention to msg boards and study DD , charts L2.
Mav
Thank u.
Ive been very patient for a reason. Come on Rik give us that steak n lobster we have all been waiting for!!!
Mav
Serious $$$$ flowing into this for a reason
Following the MONEY here
Mav
RSHN - adding this dip buckled up for the rip!
NPHC - patiently holding.
Im working dawn until dusk right now. I may not be posting all the time but im still here and the DD/Fundementals are in my sticky and written all over the wall
THIS IS THE CALM BEFORE THE STORM IMO
Mav
RSHN - seen it many many times.
We are churning out trip holders who flip for each tick and think they made bank cuz it hit .002s...
Once the churn is done we launch higher where it moves faster and quicker above to pennies. Its there we gain different types of traders and investors
Big things coming in the weeks ahead!!!!
Mav
LOADING and HOLDING!!!
This will be considered dirt cheap very soon! My bet is by afternoon! LOL
Mav
RSHN - I see two Major problems here...
1. People will regret selling too early.
2. People will wish they bought more.
This is got multi pennies all over it and the train is leaving the station!!! Imo
Mark it
Mav
RBIZ - 15M ++ in 19 sessions
Show us another pink sheet that has seen that kind of dollar volume in the last 19 sessions..
I'll be waiting
Mav
RBIZ - add up the dollar volume the past month.
SERIOUS $$$$$$$$.
FOLLOW THE MONEY
Mav
I agree 100%. We are good here.
Simply a matter of time now.
Finalization of the JV partnership(s) will take NPHC back to 150 mil ++ market cap.
And whatever the OS is when that happens the PPS will be far higher than here.
Mark it.
Mav
RBIZ - been accumulating all week.
Quietly LOADING the BOAT!!!... i got enough shares now!! Buckled up for the multi penny run coming here!!
Mav
Buying here.
Thank u very much!!!
NPHC- Calling all shareholders
We need to take to spreading the truth about NPHC across ihub and social media.
The last few PRs point to the fact big things are coming and the awareness hasnt set in across the markets.
I will get back into posting more DD. I'll try to find a way to fit it into my crazy long days.
If we all work together we can make the market more aware of the major developments that have happened and that are about to happen in the next 60 days!!
Exciting times ahead imo!!
Mav
NPHC - Shorts better cover here.
Awareness is growing that NPHC is extremely UNDERVALUED and UNDER the radar.
Our time wil come when the games no longer have an effect on the share price and those trying to hold us back and accumulate no longer have power over the PPS.
Longs know darn well this company is extremely UNDERVALUED at this point and only very impatient or uninformed are selling here at rock bottom. Imo
Mav
Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing
Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products.
June 28, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation(OTC: NPHC), a biotechnology company marketing Nyloxin®and Pet Pain-Away™in the over-the-counter (OTC) pain management marketand which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they had signed a definitive Letter of Intent for a $4 Million financing that will fund a subsidiary joint venture.
JAH Neal Holdings LLC will act as the minority Joint Venture (JV) partner with a 49% stake in the subsidiary for their $4 million investment. Nutra Pharma will maintain a 51% stake in the venture and will contribute an exclusive license for all of their Over-the-Counter (OTC) products, which currently includes: Nyloxin®, Pet Pain-Away™ and Luxury Feet. The stakeholders will jointly manage the JV.
“We’ve been working diligently to increase the exposure, sales and distribution of our OTC product line,” commented Rik J Deitsch, CEO of Nutra Pharma Corporation. "The one thing that we were missing was a large cash infusion to be able to scale up manufacturing and market these products effectively. With the $4 million coming into the JV, we have a definitive plan to roll out national distribution that includes online, direct to consumer and retail sales," he continued. "With the nation focused on the treatment of chronic pain and the reduction of opiate use,we believe that our opioid-free solutions, including Nyloxin and Pet Pain-Away, will be the products of choice for chronic pain with the right marketing and consumer education," he concluded.
Nyloxin® is a safe, non-narcotic, and non-addictive Homeopathic pain reliever clinically proven to treat moderate to severe chronic pain while not impairing cognitive function. Nyloxin® offers several benefits as pain relievers and anti-inflammatory agents. With increasing concern about consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an opioid-free alternative that does not rely on opiates or non-steroidal anti-inflammatory drugs, otherwise known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile. Since the early 1930s, the active pharmaceutical ingredient (API), Asian cobra venom, has been studied in more than 46 human clinical studies.
Pet Pain-Away™ is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever. The product is primarily aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in dogs and cats. Specialized proteins in Pet Pain-Away™ block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.
“We’re very excited to be working with Nutra Pharma on this project,” commented Jeff Neal, President of JAH Neal Holdings LLC. “We see a real need for these products as the country is looking for alternatives to potentially dangerous opioid drugs. We also see the need for better solutions to treating pain in our companion animals,” he continued. “We’ve been impressed by the power of Nyloxin and Pet Pain-Away. It’s clear that these products are effective. We believe that the only thing missing from making these products a household name is the cash infusion to begin a broad marketing and distribution platform. It will be our short-term goal to get these products into national retailers with a push to global sales in 2019,” he concluded.
All of the parties are working diligently to complete the necessary steps to enact the creation, funding and launch of the Joint Venture subsidiary with a plan to complete the transactions by the end of the summer.
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brand Nyloxin® and Pet Pain-Away™.
For additional information about Nutra Pharma, visit:
www.NutraPharma.com
http://www.nyloxin.com
http://www.petpainaway.com
Nutra Pharma Announces Direct Mail Campaign for Pet Pain-Away™ Private Label Brand
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™through their direct response partner, DEG Productions.
July 3, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation(OTC: NPHC), a biotechnology company marketing Nyloxin®and Pet Pain-Away™in the over-the-counter (OTC) pain management market, announced today that DEG Productions has signed an exclusive distribution deal with one of the nation’s leading direct mail marketers to launch a private label version of Pet Pain-Away™.
“Since we announced the new Pet Pain-Away marketing campaign by DEG, they have already created expanding product sales and a spike in national product recognition,” commented Rik J Deitsch, CEO of Nutra Pharma Corporation. "DEG is creating sales and educating new product users through infomercials (direct marketing) as well as online marketing and social media," he continued. "Their advertising features companion animals that are actual product users. This new agreement will allow access to a large population of the country that may not see the online or television advertising, but can be reached through catalog sales and direct mail marketing. It’s a completely untapped market for our products and includes millions of pet owners," he concluded.
Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever. The product is primarily aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in dogs and cats. Specialized proteins in Pet Pain-Away block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.
“We are very excited about the sales opportunity that this highly targeted campaign presents,” commented Dan Sladkus, Co-President of DEG Productions. “The product will be marketed nationally to a proven list of pet product buyers through a stand-alone custom mailer,” he continued. “Due to the substantial nature of this list, which can reach millions of pet owners throughout the country, we feel that we will be able to educate new customers about the benefits of the product in a highly focused and efficient way,” he concluded.
The direct mail campaign is complimentary to the ongoing television campaign in that it is designed to acquire new customers and convert them into the monthly auto-ship program.
According to The American Pet Products Association (APPA) there are 89.7 million dogs and 94.2 million cats in the US. These companion animals are as susceptible as humans to ailments that require pain-relieving solutions. The total market for companion animals in the US reached an estimated $69.5 billion in 2017. Of these expenditures, over $15 billion was spent on medication for the animals. Additionally, a 2009 survey conducted by Virbac Pharmaceuticals puts the annual US market for companion animal pain relievers at more than $250 million.
For additional information on DEG Productions, visit: www.degproductions.tv
Nutra Pharma Announces Agreement to Launch Comprehensive Internet Marketing Campaign
Nutra Pharma is announcing its agreement with an Internet marketing firm for their Over-the-Counter Pain Remedies: Nyloxin® and Pet Pain-Away™
July 17, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation(OTC: NPHC), a biotechnology company marketing Nyloxin®and Pet Pain-Away™in the over-the-counter (OTC) pain management market, announced today that it has executed an agreement with American Marketing Technologies (“AMT”) to launch an integrated Internet marketing campaign combined with a program to target a number of national retail chains.
“According to a 2016 article published in the Washington Post, over 35 percent of adults in the United States have been on prescription pain killers; which is around 85 million people,” commented Rik J Deitsch, CEO of Nutra Pharma Corporation. “With more than 80 percent of Americans currently shopping online, it’s clear that we need the expertise of AMT to educate and market our products to the people that need them most,” he continued. “We have already begun working with this firm and are seeing great progress and we roll out our message: these are powerful, non-narcotic pain relievers that address the opioid crisis in a safe and sustainable way,” he concluded.
Nutra Pharma re-launched their product websites recently, but had not yet defined their plans for marketing and growth of their OTC product lines. The Company also recently announced the infomercial campaigns specifically promoting Pet Pain-Away™.
“AMT’s approach to market these exceptional pain-relief products is to create more awareness through social media and online marketing while trying to have these products available on shelves across the country,” stated Pablo Lavigna, AMT’s Chief Technology Officer. “Our team will provide Nutra Pharma with the ability to reach their vast audience of potential users through SEO and more traditional distribution channels in a staged and consistent manner. As we build brand awareness online; it will provide the pull-through to put these amazing products on store shelves throughout the US,” he concluded.
Nyloxin®is a safe, non-narcotic, and non-addictive Homeopathic pain reliever clinically proven to treat moderate to severe chronic pain while not impairing cognitive function. Nyloxin®offers several benefits as pain relievers and anti-inflammatory agents. With increasing concern about consumers using opioid and acetaminophen-based pain relievers, Nyloxin®offers an opioid-free alternative that does not rely on opiates or non-steroidal anti-inflammatory drugs, otherwise known as NSAIDs, for their pain relieving effects. Nyloxin®has a well-defined safety profile. Since the early 1930s, the active pharmaceutical ingredient (API), Asian cobra venom, has been studied in more than 46 human clinical studies.
Pet Pain-Away™ is a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever. The product is primarily aimed at treating moderate to severe chronic pain in companion animals. It is specifically indicated to treat pain from hip dysplasia, arthritis pain, joint pain, and general chronic pain in dogs and cats. Specialized proteins in Pet Pain-Away™ block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off.
About American Marketing Technologies, LLC
American Marketing Technologies is a digital marketing company that specializes in maximizing online presence. From branding and website design to Search Engine Optimization (SEO), its team provides the resources to make businesses more successful in today’s competitive digital economy.The best product or service will never reach the thousands of potential customers who are searching the Internet daily if it is not effectively marketed online. Its mission is to ensure clients achieve top search engine rankings and to convert clicks into customers.
For additional information on American Marketing Technologies, visit:
www.amarketingtech.com
I advise people to actually READ the PR and you will see it is NOT the same as the one on July 3rd. The news keeping coming as we get closer to the next BIG DEVELOPMENTS!!
Mav
NPHC - anything IS possible
If APR* can run to .05+ with the size of its AS and OS. Then NPHC has legitimate chance at .02 to .05 imho
Mav
NPHC - HOLDING.
No way im selling at rock bottom market cap of 3 million...
Even fully totally diluted and maxed out AS of 8 bil is market cap of 10.4mil. (Thats not going to happen but it puts things in persepective)
The shell is worth more than 24mil carry forward debt write offs...
This is how UNDERVALUED NPHC is down here at this price. No wonder there is 10s of millions on the bid below and hundreds of millions accumulated at this level the past few months.
I will wait thank u very much. Back to managing my construction company in the meantime.
Mav